Breaking News Instant updates and real-time market news.

HPQ

HP Inc.

$15.30 /

-0.185 (-1.20%)

, XRX

Xerox

$18.54 /

+1.05 (+6.00%)

16:19
03/25/20
03/25
16:19
03/25/20
16:19

HP says it should not focus on talks with Xerox amid COVID-19 pandemic

HP Inc. (HPQ) issued a letter to shareholders, saying it is focused on managing the COVID-19 pandemic "with urgency and a deep sense of care." "Our primary responsibility in this difficult period is to focus on HP's business and address the needs of our ecosystem of stakeholders around the world, including our shareholders, our millions of customers, our 250,000 partners, and our team of approximately 55,000 employees," the company said. "We are actively managing many challenges, including assuring the health and safety of our people, addressing supply chain disruptions, monitoring and addressing our customers' liquidity needs and, more broadly, ensuring HP is well-positioned to support people working remotely. At the same time, we are committed to protecting your investment in HP. Since Xerox (XRX) launched its unsolicited exchange offer and nominated directors, the global social, economic and financial environments have changed radically. Despite this, Xerox continues to advance its tender offer and its proposed slate of directors in an effort to force a combination. It is important for shareholders to understand that, under these circumstances and consistent with our fiduciary duties, we believe that we should not divert valuable time, attention and resources to a dialogue with Xerox about its proposed transaction. Any complex, large-scale, highly leveraged transaction in the current economic environment could be disastrous for HP, its shareholders and our entire ecosystem. While we remain open-minded about M&A as a tool to add value for HP shareholders at the right time and on the right terms - it's abundantly clear that now is not that time. Our focus must now be on ensuring that we remain strong and resilient throughout this crisis while continuing to position the business for the opportunities ahead. This includes continuing to advance our leadership in our core businesses and disrupting new industries with breakthrough innovation, while significantly reducing our costs to become a more agile company." HP aded in the letter that it has "consistently" expressed "deep concerns" about the capital structure that is reflect in Xerox's proposal and that it is "important" for shareholders to understand that there would 6-12 months of "significant uncertainty" before knowing whether the conditions are satisfied. "We believe the Xerox proposal fundamentally undervalues HP, threatens the future of both companies, and creates an unacceptable level of risk to both HP and Xerox shareholders," HP said. Our duty now is to protect our organization - and your investment. And that's exactly what we are going to do."

HPQ

HP Inc.

$15.30 /

-0.185 (-1.20%)

XRX

Xerox

$18.54 /

+1.05 (+6.00%)

HPQ HP Inc.
$15.30 /

-0.185 (-1.20%)

03/19/20 Loop Capital
HP Inc. price target lowered to $20 from $28 at Loop Capital
03/12/20
Fly Intel: Top five analyst upgrades
03/12/20 JPMorgan
JPMorgan upgrades to HP to Overweight, says buy ahead of catalysts
03/12/20 JPMorgan
HP Inc. upgraded to Overweight from Neutral at JPMorgan
XRX Xerox
$18.54 /

+1.05 (+6.00%)

02/25/20 Morgan Stanley
HP Inc. price target raised to $24 from $21 at Morgan Stanley
02/25/20 Deutsche Bank
HP Inc. price target raised to $24 from $22 at Deutsche Bank
02/25/20 Loop Capital
HP Inc. upgraded to Buy from Hold at Loop Capital

TODAY'S FREE FLY STORIES

General news
Redbook Store Sales data reported » 08:57
03/31/20
03/31
08:57
03/31/20
08:57

Week of 3/28 Redbook…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Downgrade
Shionogi downgraded to Hold from Buy at Jefferies » 08:57
03/31/20
03/31
08:57
03/31/20
08:57
SGIOY

Shionogi

$0.00 /

+ (+0.00%)

Jefferies analyst Stephen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Sterling Construction subsidiary awarded $20.3M California bridge project » 08:56
03/31/20
03/31
08:56
03/31/20
08:56
STRL

Sterling Construction

$8.95 /

-0.04 (-0.44%)

Sterling Construction…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Politico to hold a webinar » 08:55
03/31/20
03/31
08:55
03/31/20
08:55

Webinar entitled,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Domino's Pizza price target lowered to $316 from $335 at Wells Fargo » 08:55
03/31/20
03/31
08:55
03/31/20
08:55
DPZ

Domino's Pizza

$344.71 /

+6.26 (+1.85%)

Wells Fargo analyst Jon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Xenon Pharmaceuticals expects cash to fund operations into 2022 » 08:55
03/31/20
03/31
08:55
03/31/20
08:55
XENE

Xenon Pharmaceuticals

$10.99 /

-0.01 (-0.09%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Notable open interest changes for March 31st » 08:55
03/31/20
03/31
08:55
03/31/20
08:55
AAPL

Apple

$254.79 /

+7.05 (+2.85%)

, BAC

Bank of America

$22.03 /

+0.44 (+2.04%)

, MSFT

Microsoft

$160.31 /

+10.65 (+7.12%)

, BA

Boeing

$152.25 /

-9.755 (-6.02%)

Monday's total…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Xenon Pharmaceuticals says no change to previous guidance on FX301 » 08:55
03/31/20
03/31
08:55
03/31/20
08:55
XENE

Xenon Pharmaceuticals

$10.99 /

-0.01 (-0.09%)

, FLXN

Flexion

$8.21 /

+ (+0.00%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
U.S. equities have moved lower » 08:55
03/31/20
03/31
08:55
03/31/20
08:55

U.S. equities have moved…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Tabula Rasa HealthCare resilient in face of COVID-19, says Baird » 08:54
03/31/20
03/31
08:54
03/31/20
08:54
TRHC

Tabula Rasa HealthCare

/

+

Baird analyst Matthew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
CUI Global price target raised to $3 from $2 at Lake Street » 08:54
03/31/20
03/31
08:54
03/31/20
08:54
CUI

CUI Global

$0.95 /

+0.0899 (+10.45%)

Lake Street analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Xenon Pharmaceuticals says no change to previous guidance on NBI-921352 » 08:54
03/31/20
03/31
08:54
03/31/20
08:54
XENE

Xenon Pharmaceuticals

$10.99 /

-0.01 (-0.09%)

, NBIX

Neurocrine

$91.69 /

+3.07 (+3.46%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Xenon Pharmaceuticals expects results from Phase 2 study of XEN007 in 2020 » 08:53
03/31/20
03/31
08:53
03/31/20
08:53
XENE

Xenon Pharmaceuticals

$10.99 /

-0.01 (-0.09%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Legacy Housing price target lowered to $14 from $21 at Lake Street » 08:52
03/31/20
03/31
08:52
03/31/20
08:52
LEGH

Legacy Housing

$9.86 /

-0.13 (-1.30%)

Lake Street analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
MasterCard price target lowered to $325 from $370 at Wells Fargo » 08:52
03/31/20
03/31
08:52
03/31/20
08:52
MA

MasterCard

$252.83 /

+5.35 (+2.16%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Xenon expects FDA feedback on Phase 3 trial design for XEN496 in 2Q20 » 08:52
03/31/20
03/31
08:52
03/31/20
08:52
XENE

Xenon Pharmaceuticals

$10.99 /

-0.01 (-0.09%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Visa price target lowered to $205 from $230 at Wells Fargo » 08:51
03/31/20
03/31
08:51
03/31/20
08:51
V

Visa

$165.53 /

+4.06 (+2.51%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Xenon expects topline data for XEN1101 Phase 2b trial in 1H21 » 08:50
03/31/20
03/31
08:50
03/31/20
08:50
XENE

Xenon Pharmaceuticals

$10.99 /

-0.01 (-0.09%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Rebalancing put on hold in some cases, according to Bloomberg » 08:50
03/31/20
03/31
08:50
03/31/20
08:50

Rebalancing put on hold…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Tesla would be prudent to lower delivery guidance, says Baird » 08:49
03/31/20
03/31
08:49
03/31/20
08:49
TSLA

Tesla

$501.85 /

-12.955 (-2.52%)

Baird analyst Ben Kallo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Federal Reserve announces establishment of temporary FIMA repo facility » 08:49
03/31/20
03/31
08:49
03/31/20
08:49
SPY

SPDR S&P 500 ETF Trust

$261.57 /

+8.18 (+3.23%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

The Federal Reserve…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Xenon seeing significant reduction in enrollment for XEN1101 Phase 2b trial » 08:49
03/31/20
03/31
08:49
03/31/20
08:49
XENE

Xenon Pharmaceuticals

$10.99 /

-0.01 (-0.09%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Monolithic Power price target lowered to $190 from $200 at Needham » 08:49
03/31/20
03/31
08:49
03/31/20
08:49
MPWR

Monolithic Power

/

+

Needham analyst N. Quinn…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Dollar General upgraded to Overweight at Wells Fargo amid COVID-19 crisis » 08:49
03/31/20
03/31
08:49
03/31/20
08:49
DG

Dollar General

$146.61 /

+0.49 (+0.34%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Xenon Pharmaceuticals expects cash to fund operations into 2022 » 08:48
03/31/20
03/31
08:48
03/31/20
08:48
XENE

Xenon Pharmaceuticals

$10.99 /

-0.01 (-0.09%)

Xenon Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.